IL27 and atherosclerosis: To determine whether the administration of recombinant IL-27 affects the progression of atherosclerosis, we treated ApoE−/− mice with IL-27/anti-IL-27p28 antibody/PBS for another 8 weeks after 8 weeks of western diet consumption.